TransMedics Group Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +22.2% | +19.3% | +18.0% | -4.9% | +11.8% | +18.0% | +9.6% | -8.6% | +11.8% | +8.2% | +9.2% | – | |
| – | +29.0% | +11.2% | +22.1% | +6.1% | +3.5% | +11.5% | +9.9% | -2.5% | +13.7% | +8.1% | +5.5% | – | |
| – | +17.9% | +24.9% | +15.5% | -12.0% | +18.4% | +22.5% | +9.5% | -12.4% | +10.5% | +8.3% | +11.9% | – | |
| – | -71.9% | +5.8% | +21.8% | +2.9% | +15.4% | +4.2% | -7.1% | -4.2% | +35.7% | +20.2% | +27.1% | – | |
| – | +12.7% | +4.6% | +18.6% | -0.6% | +10.0% | -7.0% | +1.1% | +1.9% | +11.7% | +10.9% | -3.8% | – | |
| – | -34.3% | +4.7% | +19.4% | +0.5% | +11.3% | -4.1% | -1.3% | +2.1% | +17.7% | +21.8% | +1.8% | – | |
| – | – | +377.2% | +0.7% | -68.6% | +120.3% | +217.5% | +33.2% | -36.3% | -8.7% | -37.5% | +78.5% | – | |
| – | +0.4% | -0.2% | +0.7% | -0.2% | -1.3% | -3.1% | +0.4% | +0.4% | -3.9% | +113.8% | +0.8% | – | |
| – | – | +220.8% | -1.9% | -65.1% | +64.6% | +281.7% | +35.6% | -36.3% | -6.1% | -60.8% | +128.7% | – | |
| – | – | – | -120.9% | – | +355.2% | +653.0% | +28.3% | -201.0% | – | – | +303.7% | – | |
| – | – | +202.6% | 0.0% | -65.4% | +62.6% | +274.5% | +35.9% | -30.3% | +333.3% | -93.1% | +100.7% | – | |
| – | – | +84.2% | -0.1% | -36.0% | +24.5% | +123.4% | +27.9% | -28.1% | -2.7% | -15.2% | -3.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.